Figure 1.
The Igκ-LPETG mouse model. (A) The κ–LC constant region was targeted using CRISPR-Cas9 to introduce a SrtA motif at the κ C-terminus. The OB1 HC+/+ Igκ-LPETG+/+ and WT HC Igκ-LPETG+/+ mouse models have B cells of IgG1 and IgM/D BCRs, respectively. (B) The Igκ-LPETG motif on the BCR can be targeted by any substituent of choice (biotin, organic dyes, proteins, peptides, radioactive isotopes, DNA) using SrtA. SrtA cleaves between the T and G in the LPETG motif to produce an acyl-enzyme intermediate. The glycine N-terminus of the GGG motif on the probe can then initiate a nucleophilic attack resulting in a covalent (peptide) linkage of the probe to the BCR.

The Igκ-LPETG mouse model. (A) The κ–LC constant region was targeted using CRISPR-Cas9 to introduce a SrtA motif at the κ C-terminus. The OB1 HC+/+ Igκ-LPETG+/+ and WT HC Igκ-LPETG+/+ mouse models have B cells of IgG1 and IgM/D BCRs, respectively. (B) The Igκ-LPETG motif on the BCR can be targeted by any substituent of choice (biotin, organic dyes, proteins, peptides, radioactive isotopes, DNA) using SrtA. SrtA cleaves between the T and G in the LPETG motif to produce an acyl-enzyme intermediate. The glycine N-terminus of the GGG motif on the probe can then initiate a nucleophilic attack resulting in a covalent (peptide) linkage of the probe to the BCR.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close